BRPI0519325A2 - compostos, complexo antibiàtico 107891, seus fatores a1 e a2, sais farmaceuticamente aceitÁveis, processo para produzir composiÇço e uso do mesmo - Google Patents
compostos, complexo antibiàtico 107891, seus fatores a1 e a2, sais farmaceuticamente aceitÁveis, processo para produzir composiÇço e uso do mesmoInfo
- Publication number
- BRPI0519325A2 BRPI0519325A2 BRPI0519325-7A BRPI0519325A BRPI0519325A2 BR PI0519325 A2 BRPI0519325 A2 BR PI0519325A2 BR PI0519325 A BRPI0519325 A BR PI0519325A BR PI0519325 A2 BRPI0519325 A2 BR PI0519325A2
- Authority
- BR
- Brazil
- Prior art keywords
- antibiotic
- factors
- pharmaceutically acceptable
- acceptable salts
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/035,296 US7319088B2 (en) | 2003-07-18 | 2005-01-12 | Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof |
PCT/US2005/004843 WO2006075988A1 (en) | 2005-01-12 | 2005-01-19 | Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0519325A2 true BRPI0519325A2 (pt) | 2009-01-13 |
Family
ID=39705004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0519325-7A BRPI0519325A2 (pt) | 2005-01-12 | 2005-01-19 | compostos, complexo antibiàtico 107891, seus fatores a1 e a2, sais farmaceuticamente aceitÁveis, processo para produzir composiÇço e uso do mesmo |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1855705B1 (pt) |
JP (1) | JP4189026B2 (pt) |
CN (1) | CN101098707B (pt) |
AU (1) | AU2005324536B2 (pt) |
BR (1) | BRPI0519325A2 (pt) |
CA (1) | CA2593818C (pt) |
DK (1) | DK1855705T3 (pt) |
EA (1) | EA012164B1 (pt) |
ES (1) | ES2391085T3 (pt) |
HR (1) | HRP20120809T1 (pt) |
IL (1) | IL184376A0 (pt) |
MX (1) | MX2007008512A (pt) |
NO (1) | NO20073491L (pt) |
NZ (1) | NZ556369A (pt) |
PL (1) | PL1855705T3 (pt) |
RS (1) | RS52513B (pt) |
SI (1) | SI1855705T1 (pt) |
TN (1) | TNSN07262A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7351687B2 (en) * | 2003-07-18 | 2008-04-01 | Vicuron Pharmaceuticals, Inc. | Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof |
MX2011005425A (es) * | 2008-11-24 | 2011-09-27 | Sentinella Pharmaceuticals Inc Sentinella | Derivados de carboxiamida lantibiotica con actividad antibacteriana mejorada. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6218362B1 (en) * | 1997-09-08 | 2001-04-17 | Universite Laval | Lantibiotic from Streptococcus mutans and uses thereof |
US6551591B1 (en) * | 2001-09-07 | 2003-04-22 | Essential Therapeutics, Inc. | Antibiotics from microbispora |
DE602004005203T2 (de) * | 2003-07-18 | 2007-11-22 | Vicuron Pharmaceuticals, Inc. | Antibiotikum 107891, dessen Faktoren A1 und A2, pharmazeutisch annehmbare Salzeund Zusammensetzungen und Verwendung davon |
-
2005
- 2005-01-19 CA CA2593818A patent/CA2593818C/en not_active Expired - Fee Related
- 2005-01-19 NZ NZ556369A patent/NZ556369A/en not_active IP Right Cessation
- 2005-01-19 EP EP05723117A patent/EP1855705B1/en active Active
- 2005-01-19 PL PL05723117T patent/PL1855705T3/pl unknown
- 2005-01-19 MX MX2007008512A patent/MX2007008512A/es active IP Right Grant
- 2005-01-19 JP JP2007551240A patent/JP4189026B2/ja not_active Expired - Fee Related
- 2005-01-19 RS RS20120436A patent/RS52513B/en unknown
- 2005-01-19 CN CN2005800465258A patent/CN101098707B/zh not_active Expired - Fee Related
- 2005-01-19 DK DK05723117.7T patent/DK1855705T3/da active
- 2005-01-19 EA EA200701267A patent/EA012164B1/ru not_active IP Right Cessation
- 2005-01-19 BR BRPI0519325-7A patent/BRPI0519325A2/pt not_active IP Right Cessation
- 2005-01-19 ES ES05723117T patent/ES2391085T3/es active Active
- 2005-01-19 AU AU2005324536A patent/AU2005324536B2/en not_active Ceased
- 2005-01-19 SI SI200531575T patent/SI1855705T1/sl unknown
-
2007
- 2007-07-03 IL IL184376A patent/IL184376A0/en unknown
- 2007-07-05 NO NO20073491A patent/NO20073491L/no not_active Application Discontinuation
- 2007-07-11 TN TNP2007000262A patent/TNSN07262A1/fr unknown
-
2012
- 2012-10-10 HR HRP20120809TT patent/HRP20120809T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
RS52513B (en) | 2013-04-30 |
PL1855705T3 (pl) | 2012-12-31 |
AU2005324536B2 (en) | 2009-03-05 |
DK1855705T3 (da) | 2012-10-15 |
JP2008526961A (ja) | 2008-07-24 |
AU2005324536A1 (en) | 2006-07-20 |
HRP20120809T1 (hr) | 2012-11-30 |
EP1855705A1 (en) | 2007-11-21 |
NZ556369A (en) | 2009-08-28 |
EP1855705A4 (en) | 2008-11-12 |
CA2593818C (en) | 2014-12-16 |
JP4189026B2 (ja) | 2008-12-03 |
CN101098707A (zh) | 2008-01-02 |
EP1855705B1 (en) | 2012-07-11 |
CN101098707B (zh) | 2011-11-30 |
CA2593818A1 (en) | 2006-07-20 |
NO20073491L (no) | 2007-08-03 |
SI1855705T1 (sl) | 2012-11-30 |
IL184376A0 (en) | 2007-10-31 |
ES2391085T3 (es) | 2012-11-21 |
EA012164B1 (ru) | 2009-08-28 |
EA200701267A1 (ru) | 2008-02-28 |
TNSN07262A1 (fr) | 2008-12-31 |
MX2007008512A (es) | 2007-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0519942A2 (pt) | antibiótico 107891, seus fatores a1 e a2, sais e composições farmaceuticamente aceitáveis e usos dos mesmos | |
BRPI0412591A (pt) | antibiótico 107891, seus fatores a1 e a2, sais e composições farmaceuticamente aceitáveis e uso destes | |
WO2016054093A1 (en) | Altering human cutaneous microbiome to increase growth of staphylococcus epidermidis and reduce staphylococcus aureus proliferation | |
BRPI0513903A (pt) | derivados de cetolìdeos úteis como agentes antimicrobianos, seus processos de preparação e composições farmacêuticas compreendendo os mesmos | |
Zhou et al. | Synergistic effect of clinically used antibiotics and peptide antibiotics against Gram-positive and Gram-negative bacteria | |
JP2012513467A5 (pt) | ||
HRP20131170T1 (hr) | Nova antibakterijska sredstva za lijeäśenje gram-pozitivnih infekcija | |
Tyrrell et al. | The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii | |
AR073917A1 (es) | Sinergismo antibiotico | |
Giacometti et al. | In vitro activity and killing effect of the synthetic hybrid cecropin A–melittin peptide CA (1–7) M (2–9) NH2 on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics | |
US10716797B2 (en) | Steroid alkaloids and compositions and kits thereof | |
BRPI0519325A2 (pt) | compostos, complexo antibiàtico 107891, seus fatores a1 e a2, sais farmaceuticamente aceitÁveis, processo para produzir composiÇço e uso do mesmo | |
Oli et al. | Actinomycetes in medical and pharmaceutical industries | |
US9854804B2 (en) | Antifungal composition comprising polycyclic peptide compound and method for preparing the same | |
UA87546C2 (ru) | Антибиотик 107891, его факторы а1 и а2, фармацевтически приемлемые соли, композиция и их использование | |
Farrell et al. | In vitro activity of lactone ketolide WCK 4873 when tested against contemporary community-acquired bacterial pneumonia pathogens from a global surveillance program | |
Sader et al. | In vitro activity and potency of the novel oxazolidinone MRX-I tested against contemporary clinical isolates of Gram-positive bacteria | |
Sorlozano et al. | Activity of daptomycin against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae | |
Yehia et al. | Effect of linezolid alone and in combination with other antibiotics, on methicillin-resistant Staphylococcus aureus | |
US20240041976A1 (en) | Composition and use | |
Surve et al. | Toxicity of oxazolidinone linezolid on pathogenic microorganism Listeria ivanovii | |
Aktas | Efficacy of Vancomycin with Fosfomycin against Vancomycin-Resistant Enterococcus Strains Using Agar Dilution Method. | |
Sader et al. | Antimicrobial activity of daptomycin tested against S. aureus collected from osteoarticular infections | |
Takahata et al. | Bactericidal activity of garenoxacin against in vitro biofilm formed by nontypeable Haemophilus influenzae | |
MY148891A (en) | Novel antibiotic, bispolides a1, a2 and a3, and process for poducing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: NAICONS SCARL (IT) Free format text: TRANSFERIDO DE: VICURON PHARMACEUTICALS INC. |
|
B25C | Requirement related to requested transfer of rights |
Owner name: NAICONS SCARL (IT) Free format text: AFIM DE ATENDER AS DUAS TRANSFERENCIAS REQUERIDAS ATRAVES DA PETICAO NO 020100101258/RJ DE 28/10/2010, E NECESSARIO APRESENTAR O DOCUMENTO DE CESSAO DEVIDAMENTE NOTARIZADO E COM A LEGALIZACAO CONSULAR, A GUIA RELATIVA A SEGUNDA TRANSFERENCIA SOLICITADA, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA. |
|
B25A | Requested transfer of rights approved |
Owner name: NEXTHERA BIOSCIENCES S.R.L. (IT) Free format text: TRANSFERIDO DE: NAICONS S.C.A.R.L. |
|
B25A | Requested transfer of rights approved |
Owner name: SENTINELLA PHARMACEUTICALS, INC. (US) Free format text: TRANSFERIDO DE: NEXTHERA BIOSCIENCES S.R.L. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |